Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check2 days agoChange DetectedNew sections providing guidance on reading the study record, answering common questions, and how to join a study have been added, and a recruitment notice indicating no participants are being sought has been included. The 'Intervention/Treatment' label and a cited Haemophilia QoL reference have been removed.SummaryDifference0.3%

- Check10 days agoChange DetectedThe page's revision tag has been updated from v3.5.4 to v3.5.5, indicating a newer version of the content. This change is related to version tracking and does not modify the study details presented.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision tag was updated to v3.5.4 from v3.5.3, reflecting a small update to the page's metadata rather than user-facing content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s revision/version footer was updated from v3.5.2 to v3.5.3, indicating a software release change rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded glossary term: Hereditary factor VIII deficiency disease. Removed glossary term: Hemophilia A.SummaryDifference0.0%

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.